In this report, the authors outline the U.S. federal budget process for scientific R&D, discuss trends in federal R&D funding and provide an outlook for federal scientific R&D funding during the Biden administration.
Some states still face challenges with racial and ethnic disparities in COVID-19 vaccine distribution, and Texas is one of them. How might we avoid these inequities in the future? The authors explain in the Baker Institute Blog.
Elena M. Marks, Varsha Varghese, Jennifer MeierMay 5, 2021
Nonresident fellow Todd Moss testified before the U.S. House Subcommittee on Africa, Global Health and Global Human Rights on the importance of defeating energy poverty in Africa and ensuring that African countries get fair treatment in climate policy.
This brief examines the four economic pillars that are often credited with bolstering Mexico’s economy in 2019 and 2020 to determine how quickly the nation's economy will bounce back from the COVID-19 pandemic.
Tony Payan, Jose Ivan Rodriguez-SanchezApril 9, 2021
What are Mexico's prospects for immigration, trade and more, after President Andrés Manuel López Obrador's virtual meeting with President Biden? "Mexico will have to do some heavy lifting," predicts Tony Payan, director of the Center for the United States and Mexico.
Health policy experts Kirstin Matthews and Rekha Lakshmanan compare the three COVID-19 vaccines now available from Pfizer, Moderna and Johnson & Johnson and, in a separate infographic, provide an overview of Operation Warp Speed.
Vaccines and other biomedical advances will not be sufficient to halt COVID-19, unless we simultaneously counter anti-science aggression, writes Peter Hotez, fellow in disease and poverty, in a new article for PLOS Biology.
The author draws links between pandemics, the economy, nature and energy, showing that policies reducing the probability of future pandemics are a solid investment.